(Q46832008)

25 December 2017

title

A pH-stability study of phoslactomycin B and analysis of the acid and base degradation products (English)

1 reference

25 December 2017

author

Kevin A Reynolds

4

1 reference

25 December 2017

author name string

Suparna Das Choudhuri

1

1 reference

25 December 2017

Sloan Ayers

2

1 reference

25 December 2017

William H Soine

3

1 reference

25 December 2017

publication date

1 September 2005

1 reference

25 December 2017

The Journal of Antibiotics

published in

1 reference

25 December 2017

volume

58

1 reference

25 December 2017

issue

9

1 reference

25 December 2017

page(s)

573-582

1 reference

25 December 2017

https://scigraph.springernature.com/pub.10.1038/ja.2005.78

exact match

0 references

cites work

Fostriecin: chemistry and biology

1 reference

https://api.crossref.org/works/10.1038%2FJA.2005.78

Protein phosphatase 2A inhibitors, phoslactomycins. Effects on the cytoskeleton in NIH/3T3 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2005.78

Studies on new phosphate ester antifungal antibiotics phoslactomycins. I. Taxonomy, fermentation, purification and biological activities

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2005.78

7 January 2021

Studies of new phosphate ester antifungal antibiotics phoslactomycins. II. Structure elucidation of phoslactomycins A to F.

1 reference

https://api.crossref.org/works/10.1038%2FJA.2005.78

7 January 2021

Novel antitumor antibiotic phospholine. 1. Production, isolation and characterization.

1 reference

https://api.crossref.org/works/10.1038%2FJA.2005.78

7 January 2021

Novel antitumor antibiotic phospholine. 2. Structure determination

1 reference

https://api.crossref.org/works/10.1038%2FJA.2005.78

7 January 2021

Isolation and structure of phosphazomycin C

1 reference

https://api.crossref.org/works/10.1038%2FJA.2005.78

7 January 2021

A new antifungal antibiotic, phosphazomycin A

1 reference

https://api.crossref.org/works/10.1038%2FJA.2005.78

7 January 2021

Novel microbial metabolites of the phoslactomycins family induce production of colony-stimulating factors by bone marrow stromal cells. II. Isolation, physico-chemical properties and structure determination

1 reference

https://api.crossref.org/works/10.1038%2FJA.2005.78

7 January 2021

Novel microbial metabolites of the phoslactomycins family induce production of colony-stimulating factors by bone marrow stromal cells. I. Taxonomy, fermentation and biological properties.

1 reference

https://api.crossref.org/works/10.1038%2FJA.2005.78

7 January 2021

Enhancement and selective production of phoslactomycin B, a protein phosphatase IIa inhibitor, through identification and engineering of the corresponding biosynthetic gene cluster

1 reference

https://api.crossref.org/works/10.1038%2FJA.2005.78

7 January 2021

Fostriecin, an antitumor antibiotic with inhibitory activity against serine/threonine protein phosphatases types 1 (PP1) and 2A (PP2A), is highly selective for PP2A.

1 reference

https://api.crossref.org/works/10.1038%2FJA.2005.78

7 January 2021

Purification of protein phosphatase 4 catalytic subunit: inhibition by the antitumour drug fostriecin and other tumour suppressors and promoters

1 reference

https://api.crossref.org/works/10.1038%2FJA.2005.78

7 January 2021

Inhibition of the Ser-Thr phosphatases PP1 and PP2A by naturally occurring toxins

1 reference

https://api.crossref.org/works/10.1038%2FJA.2005.78

7 January 2021

Phase I and pharmacokinetic study of the topoisomerase II catalytic inhibitor fostriecin.

1 reference

https://api.crossref.org/works/10.1038%2FJA.2005.78

7 January 2021

Asymmetric total synthesis of (+)-fostriecin

1 reference

https://api.crossref.org/works/10.1038%2FJA.2005.78

7 January 2021

Total Synthesis of Fostriecin (CI-920) We thank Professor Andrew G. Myers and Scott E. Schaus for helpful discussions, and Dr. Alexandra E. Gould and Isabel K. Reichardt for important preliminary experimental work. We also thank Dr. Robert J. Schult

1 reference

https://api.crossref.org/works/10.1038%2FJA.2005.78

7 January 2021

Total synthesis of fostriecin (CI-920).

1 reference

https://api.crossref.org/works/10.1038%2FJA.2005.78

7 January 2021

Total synthesis of an antitumor antibiotic, Fostriecin (CI-920).

1 reference

https://api.crossref.org/works/10.1038%2FJA.2005.78

7 January 2021

Formal total synthesis of fostriecin

1 reference

https://api.crossref.org/works/10.1038%2FJA.2005.78

7 January 2021

Formal catalytic asymmetric total synthesis of fostriecin

1 reference

https://api.crossref.org/works/10.1038%2FJA.2005.78

7 January 2021

Fundamental role of the fostriecin unsaturated lactone and implications for selective protein phosphatase inhibition

1 reference

https://api.crossref.org/works/10.1038%2FJA.2005.78

7 January 2021

Identifiers

DOI

10.1038/JA.2005.78

1 reference

25 December 2017

1 reference

25 December 2017